Plasma B-type natriuretic peptide level is associated with left ventricular hypertrophy among obstructive sleep apnoea patients

Journal of Hypertension

Volumn 26, Issue 1, 2008, Pages 117-123

  Usui, Yasuhiro ^a   Tomiyama, Hirofumi ^a   Hashimoto, Hideki ^c   Takata, Yoshifumi ^a   Inoue, Yuichi ^b   Asano, Kihiro ^a   Kurohane, Saiko ^a   Shiina, Kazuki ^a   Hirayama, Yoji ^a   Yamashina, Akira ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b NEUROPSYCHIATRIC RESEARCH INSTITUTE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

B type natriuretic peptide; Left ventricular hypertrophy; Obesity; Sleep apnoea

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; APNEA; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIASTOLE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SLEEP APNEA SYNDROME;

EID: 37349038231     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282f06eb4     Document Type: Article

References (31)

1. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, Pacher R. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002; 105:2392-2397.
2. Cunningham AD, Morrison CE, McMurray JJ, Ford I, Morton JJ, Dargie HJ. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 2001; 86:21-26.
3. Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28:988-994.
4. Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996; 28:22-30.
5. Arias MA, Garcia-Rio F, Alonso-Fernandez A, Mediano O, Martinez I, Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 2005; 112:375-383.
6. Alam I, Lewis K, Stephens JW, Baxter JN. Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states. Obes Rev 2007; 8:119-127.
7. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004; 109:594-600.
8. McCord J, Mundy BJ, Hudson MP, Maisel AS, Hollander JE, Abraham WT, et al. Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med 2004; 164:2247-2252.
9. Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO, Harris BC, Frohlich ED. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 2004; 43:1590-1595.
10. Rechtschaffen A, Kales A. A manual of standardized terminology. Techniques and scoring systems for sleep stages of human subjects. Los Angeles: UCLA Brain Information Service/Brain Research Institute; 1968.
11. American Sleep Disorders Association. EEG arousals: scoring rules and examples. Sleep 1992; 15:173-184.
12. American Academy of Sleep Medicine. The Report of an AASM task force: sleep-related breathing disorders in adults: recommendations syndrome definition and measurement techniques in clinical research. Sleep 1999; 22:667-689.
13. Sahn DJ, DeMaria A, Kisslo J. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
14. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55:613-618.
15. Yoshimura M, Yasue H, Okumura K, Ogawa H, Jougasaki M, Mukoyama M, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993; 87:464-469.
16. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350:655-663.
17. Whalley GA, Walsh HJ, Gamble GD, Doughty RN. Comparison of different methods for detection of diastolic filling abnormalities. J Am Soc Echocardiogr 2005; 18:710-717.
18. Grandi AM, Imperiale D, Santillo R, Barlocco E, Bertolini A, Guasti L, Venco A. Natriuretic peptides as markers of preclinical cardiac disease in obesity. Eur J Clin Invest 2004; 34:342-348.
19. McKie PM, Rodeheffer RJ, Cataliotti A, Martin FL, Urban LH, Mahoney DW, et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure. Hypertension 2006; 47:874-880.
20. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, et al. Sleep-disordered breathing and cardiovascular disease cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163:19-25.
21. Linhart A, Gariepy J, Giral P, Levenson J, Siomon A. Carotid artery and left ventricular structural relationship in asymptomatic men at risk for cardiovascular disease. Atherosclerosis 1996; 127:103-112.
22. Tomiyama H, Doba N, Kushiro T, Yamashita M, Kanmatsuse K, Kajiwara N, et al. The relationship of hyperinsulinemic state of left ventricular hypertrophy, microalbuminuria, and physical fitness in borderline and mild hypertension. Am J Hypertens 1997; 10:587-591.
23. Perticone F, Maio R, Ceravolo R, Cosco C, Cloro C, Mattioli PL. Relationship between left ventricular mass and endothelium-dependent vasodilatation in never-treated hypertensive patients. Circulation 1999; 99:1991-1996.
24. Shivalkar B, Van de Heyning C, Kerremans M, Rinkevich D, Verbraecken J, De Backer W, Vrints C. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol 2006; 47:1433-1439.
25. Peppard P, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342:1378-1384.
26. Virolainen J, Ventila M, Turto H, Kupari M. Effect of negative intrathoracic pressure on left ventricular pressure dynamics and relaxation. J Appl Physiol 1995; 79:455-460.
27. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365:1046-1053.
28. Daniels LB, Clopton P, Bhalla V, Krishnaswamy P, Nowak RM, McCord J, et al. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. Am Heart J 2006; 151:999-1005.
29. Patwardhan AA, Larson MG, Levy D, Benjamin EJ, Leip EP, Keyes MJ, et al. Obstructive sleep apnea and plasma natriuretic peptide levels in a community-based sample. Sleep 2006; 29:1301-1306.
30. Groenning BA, Raymond I, Hildebrandt PR, Nilsson JC, Baumann M, Pedersen F. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart 2004; 90:297-303.
31. Vartany E, Imevbore M, O'Malley M, Manfredi C, Pasquarella C, Scinto L, Fine J. N-terminal pro-brain natriuretic peptide for detection of cardiovascular stress in patients with obstructive sleep apnea syndrome. J Sleep Res 2006; 15:424-429.